Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone (DIPD) As Salvage Therapy in Early Relapsed/Refractory Multiple MyelomaAnupama Kumar,Aaron S. Rosenberg,Edward D. Ball,Sarah M. Larson, Lindsey Sirianni,Carolyn M. Mulroney,Caitlin L. CostelloBlood(2023)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要